Synapse - Hematologic Malignancies Research

Search Within

Hematologic Malignancies Research

Results (3005)

Patterns of infectious morbidity in patients with Waldenstrom's macroglobulinaemia/lymphoplasmacytic lymphoma: A population-based study

Meeting Abstract

Lund, S. H.; Hultcrantz, M.; Goldin, L.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
Blood (2014)

Fulltext@MSK | Save

Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies

Meeting Abstract

Lesokhin, A. M.; Ansell, S. M.; Armand, P.; Scott, E. C.; Halwani, A.; Gutierrez, M.; Millenson, M. M.; Cohen, A. D.; Schuster, S. J.; Lebovic, D.; more...
Blood (2014)

Fulltext@MSK | Save

Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant

Meeting Abstract

Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
Blood (2014)

Fulltext@MSK | Save

Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study

Meeting Abstract

Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
Blood (2014)

Fulltext@MSK | Save

Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities

Meeting Abstract

Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; more...
Blood (2014)

Fulltext@MSK | Save

Series of hairy cell leukemia patients with co-existent plasma cell disorders

Meeting Abstract

Korde, N.; Mailankody, S.; Arons, E.; Braylan, R. C.; Raffeld, M.; Maestri, E.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Maric, I.; more...
Blood (2014)

Fulltext@MSK | Save

Biomarker proteasome levels predict response to combination therapy with carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients

Meeting Abstract

Korde, N.; Dosani, T.; Simakova, O.; Mailankody, S.; Costello, R.; Roschewski, M.; Yuan, C.; Stetler-Stevenson, M.; Figg, W. D.; Landgren, O.; more...
Blood (2014)

Fulltext@MSK | Save

Phase I trial of targeted alpha-particle therapy using actinium-225 (Ac-225)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Wahl, R. L.; Earle, D.; more...
Blood (2014)

Fulltext@MSK | Save

Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations

Meeting Abstract

Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
Blood (2014)

Fulltext@MSK | Save

Leukemia-associated oncometabolite 2-hydroxyglutarate regulates epigenetic modifications in response to oxygen availability in cells without IDH1/2 mutations

Meeting Abstract

Intlekofer, A. M.; DeMatteo, R. G.; Finley, L. W.; Cross, J. R.; Thompson, C. B.
Blood (2014)

Fulltext@MSK | Save